Parkside Financial Bank & Trust’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.5K Sell
866
-260
-23% -$3.51K ﹤0.01% 1580
2026
Q1
$15.6K Hold
1,126
﹤0.01% 1414
2025
Q4
$15.8K Buy
1,126
+165
+17% +$2.31K ﹤0.01% 1382
2025
Q3
$13.4K Hold
961
﹤0.01% 1400
2025
Q2
$14.4K Buy
961
+656
+215% +$9.37K ﹤0.01% 1371
2025
Q1
$4.02K Buy
+305
New +$4.21K ﹤0.01% 1697

Other funds holding RDY

Parkside Financial Bank & Trust's RDY Position: Q2 2026 in Review

Parkside Financial Bank & Trust reduced its Dr. Reddy's Laboratories (RDY) stake by 23% in Q2 2026, selling an estimated $3.51K and leaving 866 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1580.

Parkside Financial Bank & Trust first reported a position in RDY in Q1 2025 and has held it in 6 quarters since. The position peaked at $15.8K in Q4 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Parkside Financial Bank & Trust held 866 shares of Dr. Reddy's Laboratories worth $12.5K as of Q2 2026.
  • Parkside Financial Bank & Trust sold 260 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $3.51K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1580 holding.
  • Parkside Financial Bank & Trust first reported a position in Dr. Reddy's Laboratories in Q1 2025 and has held it in 6 quarters since.
  • Parkside Financial Bank & Trust's Dr. Reddy's Laboratories position peaked at $15.8K in Q4 2025.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.